These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1620210)
1. Role of biologic markers in epidemiologic studies of prenatal drug exposure: issues in study design. Bracken MB; Leaderer B; Belanger K NIDA Res Monogr; 1992; 117():41-60. PubMed ID: 1620210 [No Abstract] [Full Text] [Related]
3. Drug addiction and pregnancy: a different perspective. Custo GM; Saitto C; Minozzi M Acta Eur Fertil; 1988; 19(2):105-6. PubMed ID: 3223193 [No Abstract] [Full Text] [Related]
4. Studies of prenatal drug exposure and environmental research issues: the benefits of integrating research within a treatment program. Kaltenbach KA; Finnegan LP NIDA Res Monogr; 1992; 117():259-70. PubMed ID: 1620201 [No Abstract] [Full Text] [Related]
5. Who is it going to be? Subject selection issues in prenatal drug exposure research. Fried PA NIDA Res Monogr; 1992; 117():121-36. PubMed ID: 1620191 [No Abstract] [Full Text] [Related]
6. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health. Koren G; Hutson J; Gareri J Clin Pharmacol Ther; 2008 Apr; 83(4):631-4. PubMed ID: 18288086 [TBL] [Abstract][Full Text] [Related]
8. Substance abuse in pregnant women: making improved detection a good clinical outcome. Araojo R; McCune S; Feibus K Clin Pharmacol Ther; 2008 Apr; 83(4):520-2. PubMed ID: 18349872 [TBL] [Abstract][Full Text] [Related]
9. Detection of prenatal drug exposure in the pregnant woman and her newborn infant. Ostrea EM NIDA Res Monogr; 1992; 117():61-79. PubMed ID: 1620211 [No Abstract] [Full Text] [Related]
10. Smoking patterns and outcomes in a population of pregnant women with other substance use disorders. Burns L; Mattick RP; Wallace C Nicotine Tob Res; 2008 Jun; 10(6):969-74. PubMed ID: 18584460 [TBL] [Abstract][Full Text] [Related]
11. Determination of the prevalence of drug misuse by meconium analysis. Williamson S; Jackson L; Skeoch C; Azzim G; Anderson R Arch Dis Child Fetal Neonatal Ed; 2006 Jul; 91(4):F291-2. PubMed ID: 16790733 [TBL] [Abstract][Full Text] [Related]
12. Prenatal substance use in a Western urban community. Buchi KF; Varner MW West J Med; 1994 Nov; 161(5):483-6. PubMed ID: 7810126 [TBL] [Abstract][Full Text] [Related]
13. Drug abuse during pregnancy in an inner-city hospital: prevalence and patterns. Land DB; Kushner R J Am Osteopath Assoc; 1990 May; 90(5):421-6. PubMed ID: 2354963 [TBL] [Abstract][Full Text] [Related]
14. Perinatal substance abuse and the drug-exposed neonate. Bennett AD Adv Nurse Pract; 1999 May; 7(5):32-6; quiz 37-8. PubMed ID: 10578732 [TBL] [Abstract][Full Text] [Related]
15. Meconium drug screening to detect prenatal substance abuse. Wildman KM; Mohl V; Houston R; Allerheiligen D J Fam Pract; 1996 Nov; 43(5):501-2. PubMed ID: 8917151 [No Abstract] [Full Text] [Related]
16. Measurement of substance use during pregnancy: methodologic issues. Day NL; Wagener DK; Taylor PM NIDA Res Monogr; 1985; 59():36-47. PubMed ID: 3929131 [No Abstract] [Full Text] [Related]
17. [Pregnancy of a drug-abuser]. Halmesmäki E Duodecim; 2000; 116(14):1513-8; quiz 1519, 1471. PubMed ID: 12001470 [No Abstract] [Full Text] [Related]